Gary Phillips

Gary Phillips is the current president of the San Diego Tech Coast Angels, an affiliate of the largest angel investor group in the United States. Members of the Tech Coast Angels provide funding and guidance to more early-stage, high-growth companies in Southern California than any other investment group.

Recent posts

Help Save Our Innovation Economy from the SEC’s Rewrite of Reg D
Over the past 30 years, the United States has developed an infrastructure to nurture, grow, and fund early stage companies that is the envy of the world. There are more than... Read more »
Exit Early and Often: A New Age of Limited Options for Entrepreneurs
I rarely meet an entrepreneur (or one of their investors) who doesn’t believe their venture will be a runaway hit. In three to five years, I hear over and over, we’ll... Read more »
How the TCA is Making 2013 The Year of the Angel Investor
A number of pundits have been claiming that angel investment is waning, and that such funding opportunities will remain few and far between for deserving startups seeking to take their innovations... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Video
The Importance of Early Planning for Biotechs & Engaging with a CRO for Molecule Development
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
Medpace

From Our Editors · Special Report
Xcelerating Life Sciences Philadelphia: Special Report
Becoming the Cell & Gene Therapy Hub

Sponsored · Whitepaper
Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4

FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats

Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

“Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

Gary Phillips

Recent posts

Help Save Our Innovation Economy from the SEC’s Rewrite of Reg D

Exit Early and Often: A New Age of Limited Options for Entrepreneurs

How the TCA is Making 2013 The Year of the Angel Investor

Underwriters and Partners

The Importance of Early Planning for Biotechs & Engaging with a CRO for Molecule Development

Xcelerating Life Sciences Philadelphia: Special Report

Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs

Xconomy on Demand

We offer a number of ways to subscribe for free!